Back
Shift4 Payments Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
99
FOUR
Shift4 Payments
Last Price:
100.77
Seasonality Move:
35.79%
Buy
59
ANIP
ANI Pharmaceuticals
Last Price:
61.42
Seasonality Move:
5.08%
Buy
99
Shift4 Payments (FOUR)
is a Buy
Is Shift4 Payments a Buy, Sell or Hold?
- The current Shift4 Payments [FOUR] share price is $100.77. The Score for FOUR is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- FOUR is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
59
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.67. The Score for ANIP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FOUR Stock Price Chart
What is Shift4 Payments's stock price today?
-
The Shift4 Payments share price today is $100.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOUR is experiencing slight buying pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
FOUR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.03 | Buy |
| Relative Strength Index (14 RSI): | 72.5 | Buy |
| Chaikin Money Flow: | 684294 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (90.77 - 96.13) | Buy |
| Bollinger Bands (100): | (70.24 - 90.22) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 60.46 | Buy |
| Chaikin Money Flow: | 225492 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.73 - 59.67) | Buy |
| Bollinger Bands (100): | (57.7 - 62.92) | Buy |
FOUR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.58 | Buy |
| 20-day SMA: | 93.77 | Buy |
| 50-day SMA: | 88.32 | Buy |
| 200-day SMA: | 75.22 | Buy |
| 8-day EMA: | 95.26 | Buy |
| 20-day EMA: | 93.22 | Buy |
| 50-day EMA: | 88.66 | Buy |
| 200-day EMA: | 76.92 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.22 | Buy |
| 20-day SMA: | 58.64 | Buy |
| 50-day SMA: | 58.71 | Buy |
| 200-day SMA: | 62.04 | Sell |
| 8-day EMA: | 58.8 | Buy |
| 20-day EMA: | 58.52 | Buy |
| 50-day EMA: | 58.98 | Buy |
| 200-day EMA: | 59.88 | Buy |
Shift4 Payments Earnings Growth & FOUR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and an increase next year of $1.05 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.82 per share.
Shift4 Payments Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||